ARROWHEAD PHARMACEUTICALS, INC. License Agreements
8 Contracts & Agreements
- First Amendment to Exclusive License and Co-Funding Agreement by and between Arrowhead Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. dated March 15, 2022 (Filed With SEC on May 10, 2022)
- Amendment No. 2 to License Agreement by and between Arrowhead Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc., dated February (Filed With SEC on November 25, 2019)
- Amendment No. 1 to License Agreement by and between Arrowhead Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc., dated December 18, 2018 (Filed With SEC on November 25, 2019)
- NON-EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on December 20, 2011)
- PATENT AND TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on February 10, 2011)
- CNT PRODUCTION PATENT LICENSE AGREEMENT (Filed With SEC on February 10, 2011)
- LICENSE AND ENFORCEMENT AGREEMENT (Filed With SEC on February 10, 2011)
- AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on December 14, 2006)
